Bausch Health Companies INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
10-K: Bausch Health Reports Increased Revenue in 2024, Focuses on Debt Reduction and Core Business Growth
Bausch Health Companies Inc. reports a revenue increase of 10% in 2024, driven by growth across all segments and strategic focus on core therapeutic areas.
NYSE
Bausch Health Companies Inc. released its 2023 annual report, highlighting financial performance across its segments and strategic initiatives including the potential separation of Bausch + Lomb.